![Brian Loeb](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Loeb
Directeur/Bestuurslid bij
MycoTechnology, Inc.
Profiel
Brian Loeb is currently a Director at MycoTechnology, Inc., a Director at Arzeda Corp., a Board Member at Prenexus Health LLC, a Board Member at Plasma Nutrition LLC, and Co-Head at Conti Ventures.
He previously worked as an Advisor at Magnises, Inc. from 2013 to 2014.
Mr. Loeb received a graduate degree from Yale University and a graduate degree from the London School of Economics & Political Science.
Actieve functies van Brian Loeb
| Bedrijven | Functie | Begin |
|---|---|---|
Conti Ventures
 Conti Ventures Investment ManagersFinance Conti Ventures invests in companies located in the United States. The firm focuses on ag biotech, digital infrastructure, alternative protein, novel ingredients, animal health/nutrition, and downstream enterprise technology for restaurants and retailers sectors and industries. It provides financing for early and later stage capital requirements. | Corporate Officer/Principal | 01-01-2016 |
Arzeda Corp.
 Arzeda Corp. BiotechnologyHealth Technology Operates as a synthetic biology company | Directeur/Bestuurslid | - |
MycoTechnology, Inc.
 MycoTechnology, Inc. Food: Specialty/CandyConsumer Non-Durables Operates as a food technology and ingredient company that focused on transforming food with natural fermentation & fungal biology | Directeur/Bestuurslid | - |
Prenexus Health LLC
 Prenexus Health LLC Miscellaneous Commercial ServicesCommercial Services Engages in scientific research, development and production of natural prebiotic ingredients | Directeur/Bestuurslid | - |
Plasma Nutrition LLC
 Plasma Nutrition LLC Packaged SoftwareTechnology Services Builds ioProtein and other ingredient optimized supplements products | Directeur/Bestuurslid | - |
Eerdere bekende functies van Brian Loeb
| Bedrijven | Functie | Einde |
|---|---|---|
Magnises, Inc.
 Magnises, Inc. Finance/Rental/LeasingFinance Offers payment cards to registered members | Consultant / Adviseur | 01-06-2014 |
Opleiding van Brian Loeb
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
MycoTechnology, Inc.
MycoTechnology, Inc. Food: Specialty/CandyConsumer Non-Durables Operates as a food technology and ingredient company that focused on transforming food with natural fermentation & fungal biology | Consumer Non-Durables |
Magnises, Inc.
Magnises, Inc. Finance/Rental/LeasingFinance Offers payment cards to registered members | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arzeda Corp.
Arzeda Corp. BiotechnologyHealth Technology Operates as a synthetic biology company | Health Technology |
Prenexus Health LLC
Prenexus Health LLC Miscellaneous Commercial ServicesCommercial Services Engages in scientific research, development and production of natural prebiotic ingredients | Commercial Services |
Plasma Nutrition LLC
Plasma Nutrition LLC Packaged SoftwareTechnology Services Builds ioProtein and other ingredient optimized supplements products | Technology Services |
Conti Ventures
Conti Ventures Investment ManagersFinance Conti Ventures invests in companies located in the United States. The firm focuses on ag biotech, digital infrastructure, alternative protein, novel ingredients, animal health/nutrition, and downstream enterprise technology for restaurants and retailers sectors and industries. It provides financing for early and later stage capital requirements. | Finance |
